Open access
Open access
Powered by Google Translator Translator

Dermatology

NICE Guideline: Human and animal bites. Assessment, indications for antibiotic prophylaxis in uninfected bites, and choice of antibiotic are reviewed

5 Nov, 2020 | 09:02h | UTC

Human and animal bites: antimicrobial prescribing – National Institute for Health and Care Excellence

 


Systemic treatments for eczema: A network meta‐analysis

4 Oct, 2020 | 22:45h | UTC

Systemic treatments for eczema: a network meta‐analysis – Cochrane Library

 


Understanding necrotizing soft tissue infections in the intensive care unit

25 Sep, 2020 | 02:31h | UTC

Understanding necrotizing soft tissue infections in the intensive care unit – Intensive Care Medicine

 

Commentary on Twitter

 


JAMA Network Series: Medical Specialties and the COVID-19 Pandemic

24 Sep, 2020 | 09:45h | UTC

Editorial: The COVID-19 Pandemic and the JAMA Network

See articles:

 


NICE Guideline: Antimicrobial prescribing for insect bites and stings

23 Sep, 2020 | 14:40h | UTC

Insect bites and stings: antimicrobial prescribing – National Institute for Health and Care Excellence

 


Multisystem effects of COVID-19: A concise review for practitioners

16 Sep, 2020 | 09:14h | UTC

Multisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine

 


Systematic review: Interventions for American cutaneous and mucocutaneous leishmaniasis

16 Sep, 2020 | 08:47h | UTC

Interventions for American cutaneous and mucocutaneous leishmaniasis – Cochrane Library

 

Commentary on Twitter

 


Cutaneous manifestations of COVID-19: An evidence-based review

15 Sep, 2020 | 08:55h | UTC

Cutaneous Manifestations of COVID-19: An Evidence-Based Review – American Journal of Clinical Dermatology

 


8 ways the coronavirus can affect your skin, from COVID toes, to rashes and hair loss

24 Aug, 2020 | 00:35h | UTC

8 ways the coronavirus can affect your skin, from COVID toes, to rashes and hair loss – The Conversation

 


Maculopapular eruptions associated with COVID ‐19

19 Aug, 2020 | 09:29h | UTC

Maculopapular eruptions associated to COVID ‐19: a subanalysis of the COVID‐Piel study – Dermatologic Therapy

 


[Abstract Only] Meta-analysis: Point-of-care ultrasonography for the diagnosis of skin and soft tissue abscesses

3 Aug, 2020 | 01:18h | UTC

Point-of-Care Ultrasonography for the Diagnosis of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-analysis – Annals of Emergency Medicine (link to abstract – $ for full-text)

Commentary: POCUS for Abscess – A Large Meta-Analysis – Journal Feed

 


[Abstract Only] Trial of Roflumilast cream for chronic plaque psoriasis

16 Jul, 2020 | 08:15h | UTC

Trial of Roflumilast Cream for Chronic Plaque Psoriasis – New England Journal of Medicine

Commentary: Researchers discover that topical treatment improves chronic plaque psoriasis – Mount Sinai Hospital

 


Review: Extrapulmonary Manifestations of COVID-19

13 Jul, 2020 | 00:28h | UTC

Extrapulmonary manifestations of COVID-19 – Nature Medicine

Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology

 


[Abstract Only] Randomized Trial: Ruxolitinib Cream for Treatment of Vitiligo

12 Jul, 2020 | 23:58h | UTC

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial – The Lancet

 

Related Commentary on Twitter

 


Study Supports Link Between COVID-19 and ‘COVID Toes’

3 Jul, 2020 | 08:34h | UTC

SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases – British Journal of Dermatology

News Release: Study supports link between COVID-19 and ‘COVID Toes’ – Wiley

 


Randomized Trial: Atezolizumab, Vemurafenib, and Cobimetinib for Advanced BRAFV600 Mutation-positive Melanoma

16 Jun, 2020 | 07:48h | UTC

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet

 


Cohort Study: Fexofenadine use During Pregnancy Does Not Appear to Be Associated with Increased Risk of Adverse Fetal Outcomes

3 Jun, 2020 | 03:31h | UTC

Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes – JAMA Pediatrics (free for a limited period)

 


German Guidelines for the Diagnosis and Treatment of Perianal Dermatitis

1 Jun, 2020 | 03:49h | UTC

German S1 guidelines for the diagnosis and treatment of perianal dermatitis (anal eczema) – Journal of the German Society of Dermatology

 


EULAR Recommendations for the Management of Psoriatic Arthritis

28 May, 2020 | 09:31h | UTC

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update – Annals of Rheumatic Diseases

Editorial: EULAR PsA management recommendations 2019: can the recommendations be improved?

Commentary: EULAR releases recommendations for PsA management – Medicine Matters

 


Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients

26 May, 2020 | 09:43h | UTC

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign” – Journal of the American Academy of Dermatology

 


Classification of the Cutaneous Manifestations of COVID‐19 with 375 Illustrative Cases

1 May, 2020 | 03:43h | UTC

Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases – British Journal of Dermatology

Related: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology

Great atlas with the different cutaneous manifestations of Covid-19.

 


Case Series: Characterization of Ischemic Cutaneous Lesions Associated with Covid-19

29 Apr, 2020 | 05:14h | UTC

Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology

See also: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND From ‘COVID Toes’ to Hives, These Are the Skin Conditions Dermatologists Think Could Be Signs of Coronavirus – TIME

 


ASCO Guideline: Systemic Therapy for Melanoma

3 Apr, 2020 | 03:57h | UTC

Systemic Therapy for Melanoma: ASCO Guideline – Journal of Clinical Oncology

 


Randomized Trial: Treatment of Advanced AIDS-associated Kaposi Sarcoma in Resource-limited Settings

8 Mar, 2020 | 20:16h | UTC

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial – The Lancet (free)

 


FDA Safety Alert: Montelukast May Cause Serious Mental Health Side Effects

6 Mar, 2020 | 10:22h | UTC

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis – U.S. Food & Drug Administration (free)

Commentary: Montelukast to Get Boxed Warning – NEJM Journal Watch (free)

 


Stay Updated in Your Specialty

 

No spam, just news.